Short Interest in XOMA Co. (NASDAQ:XOMAO) Decreases By 38.2%

XOMA Co. (NASDAQ:XOMAO) was the recipient of a significant drop in short interest during the month of March. As of March 13th, there was short interest totaling 3,423 shares, a drop of 38.2% from the February 26th total of 5,537 shares. Based on an average daily trading volume, of 1,474 shares, the days-to-cover ratio is currently 2.3 days.

XOMA Stock Performance

XOMAO opened at $25.38 on Friday. XOMA has a fifty-two week low of $23.32 and a fifty-two week high of $25.76. The company’s 50-day moving average is $25.39 and its 200 day moving average is $25.42.

XOMA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Thursday, April 2nd will be issued a dividend of $0.5234 per share. This represents a $2.09 dividend on an annualized basis and a yield of 8.2%. The ex-dividend date of this dividend is Thursday, April 2nd.

About XOMA

XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.

In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.